Canaccord Adams Downgrades Dolby Laboratories (DLB) to Hold
DLB Hot Sheet
Rating Summary:5 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 24 | Down: 13 | New: 29
Canaccord Adams downgrades Dolby Laboratories (NYSE: DLB) from Buy to Hold, following sales and earnings that beat estimates, but guidance that was below expectations.
Analyst Jeff Rath said, "Dolby at its current price level appears fully valued given the growth rates implied from guidance. We therefore downgrade to a HOLD and lower our price target to $44 (from $46), which implies a 16.5x P/E based on our 2010 non-GAAP estimate, plus cash."
Analyst Jeff Rath said, "Dolby at its current price level appears fully valued given the growth rates implied from guidance. We therefore downgrade to a HOLD and lower our price target to $44 (from $46), which implies a 16.5x P/E based on our 2010 non-GAAP estimate, plus cash."
You May Also Be Interested In
- UPDATE: UBS Downgrades Cavium Networks (CAVM) to Neutral; Changing Stance; Cutting Estimates
- Goldman Sachs Downgrades Bankrate (RATE) to Neutral
- Cantor Fitzgerald Downgrades Power-One (PWER) to Hold; Near-Term Uncertainty From Department of Commerce Decision
Create E-mail Alert Related Categories
DowngradesRelated Entities
Canaccord AdamsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
